Never heard of it? It wouldn't be surprising if you hadn't. Its $3.5 billion market cap doesn't turn many heads. It's a pre-revenue company too, which of course means it's also pre-profit. That ...
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The medications still amount to around $500 per month for those without ...
A sharp surge in drug abuse cases across Ladakh has triggered serious concern within the administration, with Lieutenant Governor Vinai Kumar Saxena warning that the growing involvement of minors and ...
“Generics account for nine out of every 10 prescriptions filled in the United States…. If drug makers are attempting to abuse the patent system to unfairly evergreen their products, they’re failing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results